Trials / Completed
CompletedNCT01531920
A Study in Healthy Subjects to Determine the Effects When Alcohol is Administered With Perampanel
A Phase 1 Study in Healthy Subjects to Determine the Safety, Tolerability, Psychomotor Function and Cognitive Effects of Perampanel When Administered With Alcohol
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 59 (actual)
- Sponsor
- Eisai Limited · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
A Phase 1 study in healthy subjects to determine the safety, tolerability, psychomotor function, and cognitive effects of perampanel when administered alone and with alcohol.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | alcohol + placebo | Part A alcohol + placebo |
| DRUG | alcohol + perampanel | Part A: alcohol + perampanel |
| DRUG | perampanel + alcohol | Part B: perampanel + alcohol |
| DRUG | placebo + alcohol | Part B: placebo + alcohol |
Timeline
- Start date
- 2010-05-01
- Primary completion
- 2011-04-01
- Completion
- 2011-04-01
- First posted
- 2012-02-13
- Last updated
- 2012-02-13
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT01531920. Inclusion in this directory is not an endorsement.